Beam Therapeutics Inc. Common Stock

S$38.06
SGD
Last updated on --.
24h volume1.41M
24h highest38.6511 SGD
24h lowest36.7990 SGD
24h Price movement+4.05%

BEAM recent prices

24 Hours
+4.05%+S$1.481
30 days
+1.81%+S$0.67314
60 days
+29.07%+S$8.238
90 days
+2.67%+S$0.98608

Key data

Previous close36.5819 SGD
Market cap3.56B SGD
Volume1.41M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount0.28739 SGD
Next ex-dividend dateFeb 4, 2014
Next payment dateMar 3, 2014
EPS diluted (TTM)-0.80470 SGD
Net income (FY)-83.08M SGD
Revenue (FY)209.49M SGD
Last report dateMay 7, 2026

About Beam Therapeutics Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
HeadquartersCAMBRIDGE
Employees (FY)522.00
Revenue per employee (FY)401.32K SGD
Net income per employee (FY)-159.15K SGD
Listed onNasdaq
Official website

BEAM conversion tables

BEAMBEAM
SGDSGD
0.5 BEAM19.03 SGD
1 BEAM38.06 SGD
5 BEAM190.31 SGD
10 BEAM380.63 SGD
SGDSGD
BEAMBEAM
0.5 SGD0.013136 BEAM
1 SGD0.026272 BEAM
5 SGD0.13136 BEAM
10 SGD0.26272 BEAM

FAQ

BEAM is trading at S$38.06, +4.05% over the last 24 hours. Track live moves on the price chart at the top of this page.
The BEAM stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. BEAM is currently trading at S$38.06, +4.05% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on BEAM price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. BEAM's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from BEAM; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against BEAM's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Beam Therapeutics Inc. Common Stock's market cap is currently 3.56B SGD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.41M
24h highest38.6511 SGD
24h lowest36.7990 SGD
24h Price movement+4.05%
BEAMBEAM
SGDSGD
Start trade with BEAM Perpetual